Sun Solaris Answerbook2 up to 1.4.2 Administrative Script AdminAddadmin access control
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.8 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Sun Solaris Answerbook2 up to 1.4.2. It has been classified as critical. This vulnerability affects unknown code of the file AdminViewError/AdminAddadmin of the component Administrative Script. Performing a manipulation results in access control. This vulnerability is reported as CVE-2002-2425. Moreover, an exploit is present.
Details
A vulnerability was found in Sun Solaris Answerbook2 up to 1.4.2 (Operating System). It has been classified as critical. This affects an unknown code block of the file AdminViewError/AdminAddadmin of the component Administrative Script. The manipulation with an unknown input leads to a access control vulnerability. CWE is classifying the issue as CWE-264. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
Sun AnswerBook2 1.2 through 1.4.2 allows remote attackers to execute administrative scripts such as (1) AdminViewError and (2) AdminAddadmin via a direct request.
The weakness was disclosed 12/31/2002 (Website). It is possible to read the advisory at archives.neohapsis.com. This vulnerability is uniquely identified as CVE-2002-2425 since 11/01/2007. The exploitability is told to be easy. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. Technical details and a public exploit are known. The attack technique deployed by this issue is T1068 according to MITRE ATT&CK.
The exploit is shared for download at exploit-db.com. It is declared as proof-of-concept. We expect the 0-day to have been worth approximately $5k-$25k.
The vulnerability is also documented in the databases at X-Force (9756), Exploit-DB (21677) and SecurityFocus (BID 5383†). Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Product
Type
Vendor
Name
Version
License
Support
- end of life (old version)
Website
- Vendor: https://www.oracle.com/sun/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 9.8VulDB Meta Temp Score: 8.8
VulDB Base Score: 9.8
VulDB Temp Score: 8.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Access controlCWE: CWE-264
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
08/02/2002 🔍12/31/2002 🔍
12/31/2002 🔍
11/01/2007 🔍
08/07/2014 🔍
02/10/2025 🔍
Sources
Vendor: oracle.comAdvisory: archives.neohapsis.com
Status: Confirmed
CVE: CVE-2002-2425 (🔍)
GCVE (CVE): GCVE-0-2002-2425
GCVE (VulDB): GCVE-100-20067
X-Force: 9756 - Sun AnswerBook2 allows unauthorized administrative scripts access
SecurityFocus: 5383 - Sun AnswerBook2 Unauthorized Administrative Script Access Vulnerability
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 08/07/2014 14:51Updated: 02/10/2025 05:34
Changes: 08/07/2014 14:51 (52), 04/20/2019 18:16 (4), 02/10/2025 05:34 (25)
Complete: 🔍
Cache ID: 216::103
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.